25 Feb 2013
(MENAFN) Gulf Pharmaceutical Industries (Julphar) announced that 2012’s profit climbed by 17.6 percent to USD54.50 million, reported Khaleej Times.
Meanwhile, operating profit went up by 8.6 percent from a year before to USD59.12 million.
The company added that gross profit grew by 11.1 percent in the year, reaching USD189.85 million, while operating profit margin was at 18.4 percent.
It is worth noting that Julphar’s sales revenue climbed by 15.3 percent from 2011, reaching USD321 million, as tender market sales increased by 22.5 percent.
15 Jan 2025
BBK Signs Strategic Partnership with Bahrain Airport Company to Develop “Express Cargo Village”
08 Jan 2025
Bank of Bahrain and Kuwait and Global Payment Services Deliver the First Advanced Fraud Prevention Solution for Wallet Provisioning in the Kingdom of Bahrain
26 Dec 2024
BBK proudly supports “Celebrate Bahrain” as a gold sponsor in cooperation with BTEA
17 Nov 2024
BBK and Asia Jewellers announce exclusive offers to its customers at Jewellery Arabia 2024
12 Nov 2024
BBK partners with Durrat Al Bahrain to offer exclusive financing for Jawhart Al Marjan
05 Nov 2024
As part of its digital transformation journey, BBK adds Google Wallet to its range of digital wallets
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more